Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 109(10): 3721-5, 2012 Mar 06.
Article in English | MEDLINE | ID: mdl-22355130

ABSTRACT

We postulated that a synergistic combination of two innate immune functions, pathogen surface recognition and lysis, in a protein chimera would lead to a robust class of engineered antimicrobial therapeutics for protection against pathogens. In support of our hypothesis, we have engineered such a chimera to protect against the gram-negative Xylella fastidiosa (Xf), which causes diseases in multiple plants of economic importance. Here we report the design and delivery of this chimera to target the Xf subspecies fastidiosa (Xff), which causes Pierce disease in grapevines and poses a great threat to the wine-growing regions of California. One domain of this chimera is an elastase that recognizes and cleaves MopB, a conserved outer membrane protein of Xff. The second domain is a lytic peptide, cecropin B, which targets conserved lipid moieties and creates pores in the Xff outer membrane. A flexible linker joins the recognition and lysis domains, thereby ensuring correct folding of the individual domains and synergistic combination of their functions. The chimera transgene is fused with an amino-terminal signal sequence to facilitate delivery of the chimera to the plant xylem, the site of Xff colonization. We demonstrate that the protein chimera expressed in the xylem is able to directly target Xff, suppress its growth, and significantly decrease the leaf scorching and xylem clogging commonly associated with Pierce disease in grapevines. We believe that similar strategies involving protein chimeras can be developed to protect against many diseases caused by human and plant pathogens.


Subject(s)
Immunity, Innate , Plant Diseases/immunology , Vitis/immunology , Vitis/microbiology , Animals , Bacterial Outer Membrane Proteins/physiology , California , Genes, Plant , Genetic Engineering/methods , Insect Proteins/chemistry , Peptides/chemistry , Plant Diseases/prevention & control , Plant Leaves/metabolism , Plant Physiological Phenomena/immunology , Plant Stems/metabolism , Protein Sorting Signals , Rabbits , Recombinant Fusion Proteins/chemistry , Transgenes , Xylella/genetics
2.
Adv Exp Med Biol ; 598: 342-57, 2007.
Article in English | MEDLINE | ID: mdl-17892223

ABSTRACT

This chapter summarizes our studies on the three toll-like receptor pathways, namely TLR4, TLR2, and TLR3, induced by lipopolysaccharides (LPS), peptidoglycan (PGN), and double-stranded RNA (dsRNA) in antigen presenting cells (APC). The particular emphasis is on the activation of human innate immune responses via cytokine and chemokine production. Three different measurements have been performed on monocytic and dendritic cells as model APCs: (i) the expression of various cytokine and chemokine genes by real-time PCR, (ii) the release of the cytokines and chemokines by ELISA, and (iii) gene expression analysis by cytokine and chemokine pathway-specific and whole genome microarrays. Real-time PCR and ELISA enable us to identify cytokines and chemokines that are produced specifically upon LPS, PGN, or dsRNA stimulation. Subsequently, microarray studies and appropriate validation experiments help us to identify genes involved in the upstream pathways that cause the induction of cytokines and chemokines. It is evident that TLR4-LPS, TLR2-PGN, and TLR3-dsRNA pathways are distinguished by the specific set of cytokines and chemokines they induce as well as by the upstream signaling events.


Subject(s)
Antigen-Presenting Cells/immunology , Immunity, Innate/immunology , Signal Transduction/physiology , Gene Expression Profiling , Gene Expression Regulation , Humans , Immunity, Innate/genetics , Lipopolysaccharides/immunology , Oligonucleotide Array Sequence Analysis , Peptidoglycan/immunology , RNA, Double-Stranded/immunology , Toll-Like Receptor 2/genetics , Toll-Like Receptor 2/immunology , Toll-Like Receptor 3/genetics , Toll-Like Receptor 3/immunology , Toll-Like Receptor 4/genetics , Toll-Like Receptor 4/immunology
3.
Toxicology ; 218(2-3): 216-28, 2006 Feb 01.
Article in English | MEDLINE | ID: mdl-16314022

ABSTRACT

Exposure to beryllium (Be) induces a delayed-type hypersensitivity immune reaction in the lungs of susceptible individuals, which leads to the onset of Be sensitivity and Chronic Beryllium Disease (CBD). Although some mechanistic aspects of CBD have begun to be characterized, very little is known about the molecular mechanisms by which Be activates the host immune response. To gain insight into the cellular response to Be exposure, we have performed global microarray analysis using a mixture of peripheral blood mononuclear and dendritic cells (PBMC/DCs) from a non-CBD source to identify genes that are specifically upregulated in response to BeSO(4) stimulation, compared to a control metal salt, Al(2)(SO(4))(3). We identified a number of upregulated immunomodulatory genes, including several chemokines in the MIP-1 and GRO families. Using PBMC/DCs from three different donors, we demonstrate that BeSO(4) stimulation generally exhibits an increased rate of both chemokine mRNA transcription and release compared to Al(2)(SO(4))(3) exposure, although variations among the individual donors do exist. We show that MIP-1 alpha and MIP-1 beta neutralizing antibodies can partially inhibit the ability of BeSO(4) to stimulate cell migration of PBMC/DCs in vitro. Finally, incubation of PBMC/DCs with BeSO(4) altered the binding of the transcription factor RUNX to the MIP-1 alpha promoter consensus sequence, indicating that Be can regulate chemokine gene activation. Taken together, these results suggest a model in which Be stimulation of PBMC/DCs can modulate the expression and release of different chemokines, leading to the migration of lymphocytes to the lung and the formation of a localized environment for development of Be disease in susceptible individuals.


Subject(s)
Beryllium/toxicity , Chemokines/metabolism , Dendritic Cells/drug effects , Gene Expression Regulation/drug effects , Leukocytes, Mononuclear/drug effects , Cell Movement/drug effects , Cells, Cultured , Chemokines/genetics , Dendritic Cells/metabolism , Gene Expression Profiling , Humans , Leukocytes, Mononuclear/metabolism , Oligonucleotide Array Sequence Analysis , Transcriptional Activation
4.
Biosens Bioelectron ; 20(4): 706-18, 2004 Nov 01.
Article in English | MEDLINE | ID: mdl-15522585

ABSTRACT

Rapid, accurate, and sensitive detection of biothreat agents requires a broad-spectrum assay capable of discriminating between closely related microbial or viral pathogens. Moreover, in cases where a biological agent release has been identified, forensic analysis demands detailed genetic signature data for accurate strain identification and attribution. To date, nucleic acid sequences have provided the most robust and phylogentically illuminating signature information. Nucleic acid signature sequences are not often linked to genomic or extrachromosomal determinants of virulence, a link that would further facilitate discrimination between pathogens and closely related species. Inextricably coupling genetic determinants of virulence with highly informative nucleic acid signatures would provide a robust means of identifying human, livestock, and agricultural pathogens. By means of example, we present here an overview of two general applications of microarray-based methods for: (1) the identification of candidate virulence factors; and (2) the analysis of genetic polymorphisms that are coupled to Bacillus anthracis virulence factors using an accurate, low cost solid-phase mini-sequencing assay. We show that microarray-based analysis of gene expression can identify potential virulence associated genes for use as candidate signature targets, and, further, that microarray-based single nucleotide polymorphism assays provide a robust platform for the detection and identification of signature sequences in a manner independent of the genetic background in which the signature is embedded. We discuss the strategy as a general approach or pipeline for the discovery of virulence-linked nucleic acid signatures for biothreat agents.


Subject(s)
Bacillus anthracis/isolation & purification , Bacillus anthracis/pathogenicity , Gene Expression Profiling/methods , Oligonucleotide Array Sequence Analysis/methods , Sequence Analysis, DNA/methods , Virulence Factors/analysis , Virulence Factors/genetics , Bacillus anthracis/classification , Bacillus anthracis/genetics , Environmental Monitoring/instrumentation , Environmental Monitoring/methods , Oligonucleotide Array Sequence Analysis/instrumentation , Polymorphism, Single Nucleotide/genetics
5.
Appl Environ Microbiol ; 70(2): 1068-80, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14766590

ABSTRACT

DNA from over 300 Bacillus thuringiensis, Bacillus cereus, and Bacillus anthracis isolates was analyzed by fluorescent amplified fragment length polymorphism (AFLP). B. thuringiensis and B. cereus isolates were from diverse sources and locations, including soil, clinical isolates and food products causing diarrheal and emetic outbreaks, and type strains from the American Type Culture Collection, and over 200 B. thuringiensis isolates representing 36 serovars or subspecies were from the U.S. Department of Agriculture collection. Twenty-four diverse B. anthracis isolates were also included. Phylogenetic analysis of AFLP data revealed extensive diversity within B. thuringiensis and B. cereus compared to the monomorphic nature of B. anthracis. All of the B. anthracis strains were more closely related to each other than to any other Bacillus isolate, while B. cereus and B. thuringiensis strains populated the entire tree. Ten distinct branches were defined, with many branches containing both B. cereus and B. thuringiensis isolates. A single branch contained all the B. anthracis isolates plus an unusual B. thuringiensis isolate that is pathogenic in mice. In contrast, B. thuringiensis subsp. kurstaki (ATCC 33679) and other isolates used to prepare insecticides mapped distal to the B. anthracis isolates. The interspersion of B. cereus and B. thuringiensis isolates within the phylogenetic tree suggests that phenotypic traits used to distinguish between these two species do not reflect the genomic content of the different isolates and that horizontal gene transfer plays an important role in establishing the phenotype of each of these microbes. B. thuringiensis isolates of a particular subspecies tended to cluster together.


Subject(s)
Bacillus anthracis/classification , Bacillus cereus/classification , Bacillus thuringiensis/classification , Fluorescence , Polymorphism, Restriction Fragment Length , Animals , Bacillus anthracis/genetics , Bacillus cereus/genetics , Bacillus thuringiensis/genetics , DNA Fingerprinting/methods , DNA, Bacterial/analysis , DNA, Bacterial/genetics , Deoxyribonuclease EcoRI/metabolism , Deoxyribonucleases, Type II Site-Specific/metabolism , Humans , Phylogeny , Serotyping
6.
Mol Biol Cell ; 14(2): 685-97, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12589063

ABSTRACT

Several findings have revealed a likely role for DNA ligase IV, and interacting protein XRCC4, in the final steps of mammalian DNA double-strand break repair. Recent evidence suggests that the human DNA ligase IV protein plays a critical role in the maintenance of genomic stability. To identify protein-protein interactions that may shed further light on the molecular mechanisms of DSB repair and the biological roles of human DNA ligase IV, we have used the yeast two-hybrid system in conjunction with traditional biochemical methods. These efforts have resulted in the identification of a physical association between the DNA ligase IV polypeptide and the human condensin subunit known as hCAP-E. The hCAP-E polypeptide, a member of the Structural Maintenance of Chromosomes (SMC) super-family of proteins, coimmunoprecipitates from cell extracts with DNA ligase IV. Immunofluorescence studies reveal colocalization of DNA ligase IV and hCAP-E in the interphase nucleus, whereas mitotic cells display colocalization of both polypeptides on mitotic chromosomes. Strikingly, the XRCC4 protein is excluded from the area of mitotic chromosomes, suggesting the formation of specialized DNA ligase IV complexes subject to cell cycle regulation. We discuss our findings in light of known and hypothesized roles for ligase IV and the condensin complex.


Subject(s)
Adenosine Triphosphatases/chemistry , DNA Ligases/chemistry , DNA-Binding Proteins/chemistry , Adenosine Triphosphatases/metabolism , Cell Cycle , Chromatin/metabolism , Cloning, Molecular , DNA Damage , DNA Ligase ATP , DNA Repair , DNA-Binding Proteins/metabolism , Fluorescent Antibody Technique, Indirect , Gene Library , HeLa Cells , Humans , Interphase , Microscopy, Fluorescence , Mitosis , Multiprotein Complexes , Precipitin Tests , Protein Binding , Protein Structure, Tertiary , Recombination, Genetic , Tumor Cells, Cultured , Two-Hybrid System Techniques
7.
DNA Repair (Amst) ; 1(4): 299-310, 2002 Apr 29.
Article in English | MEDLINE | ID: mdl-12509248

ABSTRACT

Ku70 protein, cooperating with Ku80 and DNA-dependent protein kinase (DNA-PK) catalytic subunit (DNA-PKcs), is involved in DNA double-strand break (DNA DSB) repair and V(D)J recombination. Recent studies have revealed increased ionizing radiosensitivity in Ku70-deficient cells. The presented study, using a human squamous cell lung carcinoma cell line, demonstrated that introduction of an antisense Ku70 nucleic acid made the cells more radio- and chemosensitive than the parental cells. Ku70 protein expression was suppressed in the cells with antisense Ku70 construct when compared to the wild-type cells. A relatively small but statistically significant increase in radiosensitivity of the cells was achieved by the introduction of the antisense Ku70. The increased radiosensitivity in vitro was accompanied by an approximately two-fold increase in alpha and alpha/beta values in a linear-quadratic model. The antisense Ku70 increased the chemosensitivity of the cells to some DNA-damaging agents such as bleomycin and methyl methanesulfonate, but not to cisplatin, mitomycin C, and paclitaxel. This system provides us with partial suppression of Ku70, and will be a useful experimental model for investigating the physiological roles of the DNA DSB repair gene.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/radiotherapy , DNA Helicases , DNA Repair/drug effects , DNA-Binding Proteins/antagonists & inhibitors , Lung Neoplasms/drug therapy , Lung Neoplasms/radiotherapy , Antigens, Nuclear/genetics , Antineoplastic Agents/therapeutic use , Blotting, Northern , Carcinoma, Squamous Cell/genetics , Colony-Forming Units Assay , DNA Damage , DNA Primers , DNA Repair/genetics , DNA, Antisense/pharmacology , DNA, Neoplasm/drug effects , DNA-Binding Proteins/genetics , Electrophoretic Mobility Shift Assay , Humans , In Vitro Techniques , Ku Autoantigen , Lung Neoplasms/genetics , Transfection , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/radiation effects , X-Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...